Your Health, We Care
Multiple studies have shown that Crizotinib exhibits significant efficacy in treating advanced NSCLC patients who are ALK positive or ROS1 positive.
Studies have shown that Crizotinib, as a neoadjuvant therapy for resectable locally advanced ALK fusion mutated NSCLC patients, can induce tumor downgrading and improve the success rate of surgical resection.
Scan code
Whatsapp
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
